INTSINTENSITY THERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of INTENSITY THERAPEUTICS, INC. against Biological Products, (No Diagnostic Substances) — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INTS본 종목 | $13M#9 | — | 1.4x#6 | — | — | 28.7%#4 | — | -126.0%#6 | — | — | -35.9%#6 | — |
| GRMLW | $28M#2 | — | 0.5x#2 | — | — | -71.6%#12 | — | -18.2%#2 | -14.6%#1 | — | -33.1%#4 | — |
| JSPR | $21M#3 | — | 14.9x#10 | — | — | 100.0%#1 | — | -0.0%#1 | — | — | -72.8%#10 | — |
| PHGE | $49M#1 | 0.1x#2 | 4.5x#8 | — | — | -104.2%#14 | — | -333.2%#9 | -377.8%#3 | — | -97.9%#15 | — |
| BCDA | $17M#4 | — | 6.3x#9 | — | -100.0%#6 | -3.5%#7 | — | -304.7%#8 | — | — | -27.0%#3 | — |
| DYAI | $16M#5 | — | — | 5.0x#1 | -11.6%#2 | -26.8%#11 | -232.8%#1 | — | — | — | -57.2%#8 | — |
| PASG | $15M#6 | — | 3.4x#7 | — | — | 29.7%#3 | — | -1021.6%#10 | — | — | -34.8%#5 | — |
| BCLI | $13M#8 | — | — | — | — | 11.3%#6 | — | — | — | — | -1.7%#2 | — |
| ENGNW | $12M#10 | 0.1x#1 | 0.1x#1 | — | — | -112.7%#15 | — | -50.9%#3 | — | — | -72.8%#9 | — |
| PLUR | $14M#7 | — | — | 13.4x#2 | -24.0%#3 | -5.5%#8 | -2454.5%#2 | — | — | — | -77.8%#13 | — |
| INAB | $11M#11 | — | 0.6x#3 | — | — | 36.1%#2 | — | -105.9%#5 | — | — | -46.0%#7 | — |
| SNTI | $10M#12 | — | — | 449.8x#5 | — | -16.4%#10 | -312631.8%#6 | — | — | — | -77.0%#12 | — |
| CERO | $7M#13 | — | — | — | — | — | — | — | — | — | -98.3%#16 | 1.8%#1 |
| AIM | $6M#14 | — | 0.8x#5 | 73.5x#4 | -48.2%#5 | 19.4%#5 | -13254.5%#4 | -180.2%#7 | -7934.7%#4 | — | -91.6%#14 | — |
| CELZ | $6M#15 | — | 0.7x#4 | 956.1x#6 | -45.5%#4 | -9.1%#9 | -102380.2%#5 | -69.3%#4 | -66.1%#2 | 3#1 | -76.2%#11 | — |
| ZIVO | $5M#16 | — | — | 31.3x#3 | 468.6%#1 | -72.1%#13 | -8498.9%#3 | — | — | — | 0.0%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice